Gastric Acid Hypersecretion: Clinical Signs, Endoscopic Diagnosis, and Comprehensive Management

Gastric hydrochloric acid is generated by oxyntic (parietal) cells located in the gastric fundus via the membrane enzyme H+/K+-ATPase (the proton pump), which exchanges intracellular hydrogen ions (H+) for luminal potassium ions (K+). This secretion is governed by three primary convergent pathways:

• Histaminergic pathway: Enterochromaffin-like (ECL) cells release histamine to activate parietal H2 receptors;
• Gastrin pathway: Gastric G cells secrete gastrin in response to amino acid peptides and antral distension;
• Cholinergic pathway: Vagal efferent release of acetylcholine under stress binds muscarinic M3 receptors, stimulating baseline secretagogue activity.

Hyperchlorhydria manifests with pathognomonic retrosternal pyrosis (heartburn), acidic regurgitation, epigastric pressure, and nocturnal burning discomfort that typically remits transiently following food ingestion.

Clinical 'red flag' alarm features mandating immediate esophagogastroduodenoscopy (EGD) include progressive dysphagia, odynophagia, unexplained weight loss, persistent hematemesis, melena (indicating active upper GI hemorrhage), and refractory microcytic iron-deficiency anemia.

Acute pharmacotherapy centers on Proton Pump Inhibitors (PPIs: omeprazole, pantoprazole, esomeprazole), which covalently bind active H+/K+-ATPases, raising intragastric pH and permitting mucosal re-epithelialization. PPIs must strictly be administered in the fasting state, 30–60 minutes prior to morning caloric intake.

Long-term maintenance integrates protective barrier agents: sodium alginate suspensions (forming an expansive neutral floating raft atop gastric contents), zinc carnosine complexes, mucilaginous flaxseed decoctions, and complete cessation of tobacco, ethanol, and gastric mucosal irritants.